Pilot Studies of Candidate Therapies for Chronic Kidney Disease

The NIH/NIDDK is soliciting applications from investigators willing to collaborate on the design and conduct of pilot studies that will better inform the design of full-scale, randomized, controlled, clinical trial(s) in Chronic Kidney Disease (CKD). Various treatments to slow or reverse progression of CKD have been tested in small trials with limited numbers of participants, but questions still remain about optimum agent(s), target population, dosing, data collection, and appropriate outcomes. 

This is a limited submission opportunity. The University may submit only one (1) proposal. Interested faculty must submit an abstract, CV, and budget to the Deans (Catherine_muzytchuk@urmc.rochester.edu) by September 28th, using the words “Chronic Kidney Disease” in the subject line. The Deans will select a candidate by October 5th.

The complete program solicitation can be found here. The optional Letter of Intent is due October 19th. Full proposals are due November 21st. It is important to remember that ORPA must receive electronic proposals five (5) business days prior to the sponsor’s deadline, along with a completed and signed University sign-off form.

 

NIH Funding Acknowledgement ** Important ** All publications resulting from the utilization of CTSI resources are required to credit the CTSI grant by including the NIH FUNDING ACKNOWLEDGEMENT and must comply with the NIH Public Access Policy.